HUP0302308A2 - Többszörösen helyettesített imidazo-piridinek mint gyomorsavkiválasztás-gátlók és ezeket tartalmazó gyógyszerkészítmények - Google Patents
Többszörösen helyettesített imidazo-piridinek mint gyomorsavkiválasztás-gátlók és ezeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0302308A2 HUP0302308A2 HU0302308A HUP0302308A HUP0302308A2 HU P0302308 A2 HUP0302308 A2 HU P0302308A2 HU 0302308 A HU0302308 A HU 0302308A HU P0302308 A HUP0302308 A HU P0302308A HU P0302308 A2 HUP0302308 A2 HU P0302308A2
- Authority
- HU
- Hungary
- Prior art keywords
- alkyl
- alkoxy
- group
- cycloalkyl
- alkenyl
- Prior art date
Links
- 150000005232 imidazopyridines Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000002731 stomach secretion inhibitor Substances 0.000 title 1
- -1 cyanomethyl group Chemical group 0.000 abstract 12
- 125000000217 alkyl group Chemical group 0.000 abstract 11
- 125000003342 alkenyl group Chemical group 0.000 abstract 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 7
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 5
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 5
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- 125000000304 alkynyl group Chemical group 0.000 abstract 4
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 4
- 125000005843 halogen group Chemical group 0.000 abstract 3
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
- 125000001118 alkylidene group Chemical group 0.000 abstract 2
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 2
- 125000005112 cycloalkylalkoxy group Chemical group 0.000 abstract 2
- 125000001544 thienyl group Chemical group 0.000 abstract 2
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 abstract 1
- 125000005530 alkylenedioxy group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 abstract 1
- 125000000842 isoxazolyl group Chemical group 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000335 thiazolyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
A találmány (1) általános képletű vegyületekre és azok sóiravonatkozik - a képletben R1 jelentése hidrogénatom vagy alkil-,cikloalkil-, cikloalkil-alkil-, alkoxi-, alkoxi-alkil-, alkoxi-karbonil-, alkenil-, alkinil-, fluorozott alkil- vagy hidroxi-alkil-csoport; R2 jelentése hidrogénatom, halogénatom vagy alkil-, aril-,cikloalkil-, cikloalkil-alkil)-, alkoxi-karbonil-, hidroxi-alkil-,alkenil-, alkinil-, fluorozott alkil- vagy ciano-metil-csoport; R3ajelentése hidrogénatom, halogénatom, fluorozott alkil-, alkil-,alkenil-, alkinil-, karboxil-, -CO-alkoxi-, hidroxi-alkil-, alkoxi-alkil-, alkoxi-alkoxi-alkil- vagy fluorozott alkoxi-alkil-csoport vagy-CONR31R32 általános képletű csoport; R3b jelentése hidrogénatom,halogénatom, fluorozott alkil-, alkil-, alkenil-, alkinil-, karboxil-,-CO-alkoxi-, hidroxi-alkil-, alkoxi-alkil-, alkoxi-alkoxi-alkil- vagyfluorozott alkoxi-alkil-csoport vagy -CONR31R32 általános képletűcsoport; R4a és R4b egyike hidrogénatomot, alkil-, alkenil-, fenil-vagy fenil-alkil-csoportot jelent, és a másik jelentése hidroxil-,alkoxi-, oxo-szubsztituált alkoxi-, cikloalkoxi-, cikloalkil-alkoxi-,hidroxi-alkoxi-, alkoxi-alkoxi-, alkoxi-alkoxi-alkoxi-, cikloalkoxi-alkoxi-, cikloalkil-alkoxi-alkoxi-, alkil-karbonil-oxi-, teljesen vagyfőként halogénszubsztituált alkoxi- vagy R41 vagy R42 csoport; vagyR4a és R4b együtt oxigénatomot vagy alkilidéncsoportot alkot; R5a ésR5b egyike hidrogénatomot, alkil-, alkenil-, fenil- vagy fenil-alkil-csoportot jelent, és a másik jelentése hidroxil-, alkoxi-, oxo-szubsztituált alkoxi-, cikloalkoxi-, cikloalkil-alkoxi-, hidroxi-alkoxi-, alkoxi-alkoxi-, alkoxi-alkoxi-alkoxi-, cikloalkoxi-alkoxi-,cikloalkil-alkoxi-alkoxi-, alkil-karbonil-oxi-, teljesen vagy főkénthalogénszubsztituált alkoxi- vagy R51 vagy R52 csoport; vagy R5a ésR5b együtt oxigénatomot vagy alkilidén-csoportot alkot; vagyegyrészről R4a és R4b egyike, másrészről R5a és R5b egyike mindenesetben hidrogénatomot vagy alkil-, alkenil-, fenil- vagy fenil-alkil-csoportot jelent, és a fennmaradt két csoport együtt alkilén-dioxi-csoportot alkot, ami adott esetben részlegesen vagy teljesenhalogénezett lehet; Arom R8, R9, R10 és R11 csoporttal szubsztituáltmono- vagy biciklusos aromás csoportot, éspedig fenil-, naftil-,pirrolil-, pirazolil-, imidazolil-, 1,2,3-triazolil-, indolil-,benzimidazolil-, furanil- (furil), benzofuranil- (benzofuril),tiofenil- (tienil), benzotiofenil(benzotienil), tiazolil-,izoxazolil-, piridinil-, pirimidinil-, kinolinil- vagy izokinolinil-csoportot jelent; és X oxigénatomot (-O-) vagy -NH- csoportot jelent.A találmány kiterjed a vegyületeket tartalmazó gyógyszerkészítményekreis. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00123133 | 2000-10-25 | ||
| PCT/EP2001/012207 WO2002034749A1 (en) | 2000-10-25 | 2001-10-23 | Polysubstituted imidazopyridines as gastric secretion inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0302308A2 true HUP0302308A2 (hu) | 2003-11-28 |
Family
ID=8170193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0302308A HUP0302308A2 (hu) | 2000-10-25 | 2001-10-23 | Többszörösen helyettesített imidazo-piridinek mint gyomorsavkiválasztás-gátlók és ezeket tartalmazó gyógyszerkészítmények |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US6869949B2 (hu) |
| EP (1) | EP1332143A1 (hu) |
| JP (1) | JP2004512338A (hu) |
| KR (1) | KR20040011423A (hu) |
| CN (1) | CN1692113A (hu) |
| AU (2) | AU2002210563B2 (hu) |
| BR (1) | BR0114873A (hu) |
| CA (1) | CA2426616A1 (hu) |
| EA (1) | EA008151B1 (hu) |
| HR (1) | HRP20030323A2 (hu) |
| HU (1) | HUP0302308A2 (hu) |
| IL (1) | IL154850A0 (hu) |
| MX (1) | MXPA03003706A (hu) |
| NO (1) | NO325736B1 (hu) |
| NZ (1) | NZ525281A (hu) |
| PL (1) | PL360412A1 (hu) |
| SK (1) | SK5072003A3 (hu) |
| WO (1) | WO2002034749A1 (hu) |
| ZA (1) | ZA200302038B (hu) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2426616A1 (en) * | 2000-10-25 | 2002-05-02 | Altana Pharma Ag | Polysubstituted imidazopyridines as gastric secretion inhibitors |
| DE10145457A1 (de) * | 2001-09-14 | 2003-04-03 | Basf Ag | Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen |
| KR20040081204A (ko) | 2002-02-15 | 2004-09-20 | 알타나 파마 아게 | 트리시클릭 ｎ-아실 화합물 |
| TWI295575B (en) * | 2002-04-24 | 2008-04-11 | Altana Pharma Ag | Nitrosated imidazopyridines |
| MXPA05006349A (es) * | 2002-12-20 | 2005-08-26 | Altana Pharma Ag | 8-trialquisiloxi -2-metil -9-fenil -7- oxo-7, 8, 9, 10- tetrahidroimidazo [1, 2h] [1, 7]. |
| BRPI0407541A (pt) * | 2003-02-17 | 2006-02-14 | Altana Pharma Ag | combinações e uso de compostos farmaceuticamente ativos selecionados |
| US20060194972A1 (en) * | 2003-04-03 | 2006-08-31 | Altana Pharma Ag | Process for the production of imidazopyridin-8-ones |
| AR044129A1 (es) * | 2003-05-06 | 2005-08-24 | Altana Pharma Ag | Compuestos intermedios de imidazopiridina. proceso de preparacion. |
| WO2005041961A1 (en) | 2003-11-03 | 2005-05-12 | Astrazeneca Ab | Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux |
| AR046893A1 (es) * | 2003-12-16 | 2005-12-28 | Altana Pharma Ag | Bencimidazoles triciclicos |
| AR046941A1 (es) * | 2003-12-19 | 2006-01-04 | Altana Pharma Ag | Imidazopiridinas triciclicas y su uso como inhibidores de secrecion de acido gastrico |
| WO2005058894A1 (en) | 2003-12-19 | 2005-06-30 | Altana Pharma Ag | Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives |
| AU2005291284A1 (en) * | 2004-10-01 | 2006-04-13 | Altana Pharma Ag | Substituted tricyclic benzimidazoles |
| AR051375A1 (es) * | 2004-10-15 | 2007-01-10 | Altana Pharma Ag | Imidazopiridinas difluoro substituidas |
| WO2008058990A1 (en) * | 2006-11-16 | 2008-05-22 | Nycomed Gmbh | 7,7-disubstituted pyrano-[2,3-c]-imidazo-[1,2-a]-pyridine derivatives and their use as gastric acid secretion inhibitors |
| WO2012027240A1 (en) * | 2010-08-23 | 2012-03-01 | Schering Corporation | Fused tricyclic inhibitors of mammalian target of rapamycin |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4468400A (en) * | 1982-12-20 | 1984-08-28 | Schering Corporation | Antiulcer tricyclic imidazo [1,2-a]pyridines |
| US4673679A (en) * | 1986-05-14 | 1987-06-16 | E. I. Du Pont De Nemours And Company | Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration |
| CA2102116A1 (en) * | 1991-05-31 | 1992-12-01 | Gary R. Schulte | Use of rapamycin prodrugs as immunosuppressant agents |
| DE4308095A1 (de) * | 1993-03-13 | 1994-09-15 | Hoechst Ag | Prodrug-Derivate von Arzneimittelwirkstoffen mit Hydroxylgruppen, Verfahren zu deren Herstellung und ihre Verwendung |
| SE9401197D0 (sv) * | 1994-04-11 | 1994-04-11 | Astra Ab | Active compounds |
| PL190803B1 (pl) * | 1997-03-24 | 2006-02-28 | Altana Pharma Ag | Związki tetrahydropirydylowe, środki farmaceutyczne zawierające te związki oraz zastosowanie tych związków |
| ZA982445B (en) * | 1997-03-24 | 1998-09-24 | Byk Gulden Lomberg Chem Fab | Tetrahydropyrido compounds |
| EP0984969B1 (en) * | 1997-05-28 | 2008-07-09 | Nycomed GmbH | Fused dihydropyrans |
| HUP0001555A3 (en) | 1997-10-30 | 2001-01-29 | Altana Pharma Ag | Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation |
| DE69905178T2 (de) * | 1998-09-23 | 2003-07-17 | Altana Pharma Ag | Tetrahydropyridoether |
| CA2349476A1 (en) * | 1998-11-03 | 2000-05-11 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Imidazonaphthyridines |
| PT1173439E (pt) * | 1999-04-17 | 2003-10-31 | Altana Pharma Ag | Haloalcoxi imidazonaftiridinas |
| AU783724B2 (en) * | 2000-03-29 | 2005-12-01 | Altana Pharma Ag | Tricyclic imidazopyridines |
| CZ20023116A3 (cs) * | 2000-03-29 | 2003-01-15 | Altana Pharma Ag | Alkylované imidazopyridinové sloučeniny |
| US20030100578A1 (en) * | 2000-03-29 | 2003-05-29 | Senn Jorg Bilfinger | Pyrano[2,3-c]imidazo[-1,2-a]pyridine derivatives for the treatment of gastrointestinal disorders |
| NZ520837A (en) * | 2000-03-29 | 2005-01-28 | Altana Pharma Ag | Prodrugs of imidazopyridine derivatives |
| CA2426616A1 (en) * | 2000-10-25 | 2002-05-02 | Altana Pharma Ag | Polysubstituted imidazopyridines as gastric secretion inhibitors |
-
2001
- 2001-10-23 CA CA002426616A patent/CA2426616A1/en not_active Abandoned
- 2001-10-23 AU AU2002210563A patent/AU2002210563B2/en not_active Ceased
- 2001-10-23 AU AU1056302A patent/AU1056302A/xx active Pending
- 2001-10-23 PL PL36041201A patent/PL360412A1/xx not_active Application Discontinuation
- 2001-10-23 WO PCT/EP2001/012207 patent/WO2002034749A1/en active IP Right Grant
- 2001-10-23 HU HU0302308A patent/HUP0302308A2/hu unknown
- 2001-10-23 IL IL15485001A patent/IL154850A0/xx unknown
- 2001-10-23 MX MXPA03003706A patent/MXPA03003706A/es active IP Right Grant
- 2001-10-23 KR KR10-2003-7005620A patent/KR20040011423A/ko not_active Application Discontinuation
- 2001-10-23 EA EA200300478A patent/EA008151B1/ru not_active IP Right Cessation
- 2001-10-23 US US10/380,624 patent/US6869949B2/en not_active Expired - Fee Related
- 2001-10-23 SK SK507-2003A patent/SK5072003A3/sk not_active Application Discontinuation
- 2001-10-23 JP JP2002537739A patent/JP2004512338A/ja active Pending
- 2001-10-23 CN CNA018177808A patent/CN1692113A/zh active Pending
- 2001-10-23 BR BR0114873-7A patent/BR0114873A/pt not_active IP Right Cessation
- 2001-10-23 EP EP01978447A patent/EP1332143A1/en not_active Withdrawn
- 2001-10-23 NZ NZ525281A patent/NZ525281A/en unknown
-
2003
- 2003-03-13 ZA ZA200302038A patent/ZA200302038B/en unknown
- 2003-04-24 NO NO20031830A patent/NO325736B1/no unknown
- 2003-04-24 HR HR20030323A patent/HRP20030323A2/hr not_active Application Discontinuation
-
2004
- 2004-05-24 US US10/851,092 patent/US7141567B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NO20031830D0 (no) | 2003-04-24 |
| BR0114873A (pt) | 2003-07-01 |
| AU2002210563B2 (en) | 2007-03-01 |
| NO20031830L (no) | 2003-04-24 |
| IL154850A0 (en) | 2003-10-31 |
| KR20040011423A (ko) | 2004-02-05 |
| EA200300478A1 (ru) | 2003-12-25 |
| CA2426616A1 (en) | 2002-05-02 |
| MXPA03003706A (es) | 2005-01-25 |
| ZA200302038B (en) | 2004-04-22 |
| CN1692113A (zh) | 2005-11-02 |
| SK5072003A3 (en) | 2003-09-11 |
| US6869949B2 (en) | 2005-03-22 |
| NZ525281A (en) | 2004-11-26 |
| JP2004512338A (ja) | 2004-04-22 |
| US20040106642A1 (en) | 2004-06-03 |
| WO2002034749A1 (en) | 2002-05-02 |
| HRP20030323A2 (hr) | 2005-04-30 |
| EA008151B1 (ru) | 2007-04-27 |
| US7141567B2 (en) | 2006-11-28 |
| US20040214852A1 (en) | 2004-10-28 |
| AU1056302A (en) | 2002-05-06 |
| PL360412A1 (en) | 2004-09-06 |
| NO325736B1 (no) | 2008-07-14 |
| EP1332143A1 (en) | 2003-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0302308A2 (hu) | Többszörösen helyettesített imidazo-piridinek mint gyomorsavkiválasztás-gátlók és ezeket tartalmazó gyógyszerkészítmények | |
| NZ506081A (en) | Inhibitors of alpha-4 mediated cell adhesion | |
| HUP0000695A2 (hu) | Benzodioxol-, benzofurán-, dihidrobenzofurán- és benzodioxánszármazékok és ezeket tartalmazó melatonerg gyógyszerkészítmények | |
| ATE302005T1 (de) | N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren | |
| MXPA02012712A (es) | N-ureidoheterocicloalquil-piperidinas como moduladores de la actividad del receptor de quimiocinas. | |
| DE69710319T2 (de) | Para-substituierte phenylpropansäure derivate als integrin-antagonisten | |
| HUP0300195A2 (hu) | Heterociklusos nátrium/proton-csere inhibitorok és ezeket tartalmazó gyógyszerkészítmények | |
| HUP9701068A2 (hu) | Mirtazapint és egy vagy több szelektív szerotoninújrafelvétel-inhibitort tartalmazó gyógyászati készítmény | |
| ATE229001T1 (de) | Zwischenprodukte verwendbar in der herstellung von enzym-inhibitoren | |
| HUP9802417A2 (hu) | Heteroaril-csoportot tartalmazó amidszármazékok, valamint ezeket a vegyületeket tartalmazó gyógyászati készítmények | |
| TW200420542A (en) | A compound having TGF β inhibition activity and a medicinal composition containing the same | |
| ATE212991T1 (de) | Thiazolidinedione- und oxazolidinedione-derivate mit antidiabetischen, hypolipidämischen und anti hypertensiven eigenschaften | |
| NZ509010A (en) | 4 to 7 Membered heterocyclic ring systems containing either nitrogen and optionally sulphur useful as inhibitors of alpha-4, beta-1 mediated cell adhesion | |
| WO2003075853A3 (en) | Cyclic derivatives as modulators of chemokine receptor activity | |
| ES2148227T3 (es) | Derivados de 1-piperazino-1,2-dihidroindeno. | |
| ECSP066658A (es) | Alfahidroxiamidas como antagonistas o agonistas inversos de bradiquinina | |
| ATE482183T1 (de) | Malonamide und malonamid-derivate als modulatoren der chemokin-rezeptor-aktivität | |
| SE7610409L (sv) | Farmakologiskt aktiva foreningar | |
| EP0751145A3 (en) | HIV protease inhibitors | |
| DK0954521T3 (da) | 4-[(thien-3-yl)methyl]-imidazoler med alfa2-adrenoceptor-agonistisk aktivitet | |
| CA2380309A1 (en) | Cable, in particular for transport or distribution of electrical energy and insulating composition | |
| DK0650485T3 (da) | 2,5-Diaryltetrahydrothiophener, -furaner og analoger til behandling af inflammatoriske forstyrrelser og immunforstyrrelser | |
| PH12021551152A1 (en) | Use of glutarimide derivative for overcoming steroid resistance and treating diseases associated with aberrant interferon gamma signaling | |
| DE50004649D1 (de) | Schutzkappe | |
| DE69608701T2 (de) | Vitamin d analoge |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |